Frusecare is the UK veterinary licensed form of frusemide made by Animalcare. It is used to reduce fluid accumulation in the body (oedema and vascular) secondary to heart, kidney and liver problems, or in certain types of injury.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Company name: Animalcare Limited
Address: Common Road
York YO19 5RU
Telephone: 01904 487687
Fax: 01904 487611
White, circular, biconvex, flat-faced tablets with bevelled edges, breakline and embossed F40 on one face, CP or DP on the reverse. Each tablet contains Frusemide 40 mg (Furosemide).
Frusecare tablets are for use in cats and dogs only, for the treatment of oedema associated with cardiac insufficiency, renal dysfunction and trauma. In animals with pulmonary oedema of cardiac origin, combined therapy with other medicinal products may be indicated. Furosemide is a potent diuretic with an onset of activity normally within 1 hour of administration and a duration of activity of approximately 4 hours.
For oral administration only. Dogs and cats above 4 kg bodyweight:
Dosage up to 5mg/kg bodyweight, or one Frusecare tablet per 8 kg bodyweight, 1 to 2 times daily with an interval of 6 to 8 hours between administrations.
For animals weighing between 4 and 8 kg, one half of one tablet should be administered. The tablets may be divided by breaking along the score line. For maintenance, the dosage should be reduced to 1-2mg/kg per day.
Do not use in animals weighing less than 4 kg.
Do not use in animals with acute glomerular nephritis, renal failure with anuria, electrolyte deficiency disease or in animals that have received an overdosage of digitalis. Do not use concurrently with aminoglycoside antibiotics or corticosteroids.
Therapeutic efficacy may be impaired by increased intake of drinking water. Where the animal's condition permits, water intake should be restricted during treatment with Frusecare tablets.
Monitoring of plasma potassium levels is advisable during periods of prolonged treatment of combined therapy with cardiac glycosides. Potassium supplements may be necessary.
Frusecare tablets may be used in pregnant and lactating animals.
Concurrent administration with aminoglycoside antibiotics may result in ototoxicity. Concurrent administration with cephalosporin antibiotics may result in nephrotoxicity. Concurrent administration with sulphonamide antibacterials may result in sulphonamide allergy. Concurrent use of corticosteroids may increase the risk of hypokalaemia.
If you notice any serious effects of other effects not mentioned in this datasheet, please inform your veterinary surgeon.
Operator warnings: Wear gloves or wash hands immediately after handling the tablets.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Do not store above 25oC. Protect from light.
Disposal: Dispose of unused product and empty containers in accordance with guidance from your local waste regulation authority.
Plastic containers of 1,000 tablets.
Do not use after the expiry date stated on the label.
To be supplied only on veterinary prescription.
UK authorised veterinary medicinal product.
All prices include VAT where applicable.
Information regarding the safe use of all licensed medication supplied in the UK can be found on the Veterinary Medicine Directorate website. Follow this link and then search for the brand name of the product to find the official Summary of Product Characteristics for that product. Unlicensed medication, such as herbal supplements, will not be found here and there is no such formal recognition of any scientifically proven therapeutic effects from any unlicensed medication.
There are currently no questions for Frusecare Tablets for Dogs & Cats - be the first to ask one!Ask A Question